Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026)
Alcon (ALC) posted quarterly Non-Current Deferred Tax Liability of $944.0 million for Q1 2026, up 545.28% year-on-year from $146.3 million in Q1 2025, and little changed on a QoQ basis from $941.0 million in Q4 2025.
Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Non-Current Deferred Tax Liability for 11 consecutive years, with $944.0 million the latest figure, recorded in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 545.28% year-over-year to $944.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $944.0 million (up 545.28% YoY) and the FY2025 annual result came in at $941.0 million, up 29.97% from the prior year.
- Non-Current Deferred Tax Liability was little changed at $944.0 million in Q1 2026 per ALC's latest filing, from $941.0 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for ALC reached as high as $2.0 billion in Q4 2022 and fell as low as -$212.0 million in Q1 2025.
- A 5-year average of $903.5 million and a median of $911.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2025 — Non-Current Deferred Tax Liability slumped 125.92% — and 2026, when it jumped 545.28%.
- Year by year, Non-Current Deferred Tax Liability stood at $2.0 billion in 2022, then tumbled by 59.99% to $797.0 million in 2023, then fell by 9.16% to $724.0 million in 2024, then climbed by 29.97% to $941.0 million in 2025, then rose by 0.32% to $944.0 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $944.0 million, $941.0 million, and $911.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944.00 Mn |
| Mar 31, 2026 | 944.00 Mn |
| Dec 31, 2025 | 941.00 Mn |
| Dec 31, 2025 | 941.00 Mn |
| Sep 30, 2025 | 911.00 Mn |
| Sep 30, 2025 | 911.00 Mn |
| Jun 30, 2025 | 857.00 Mn |
| Jun 30, 2025 | 857.00 Mn |
| Mar 24, 2025 | -212.00 Mn |
| Mar 24, 2025 | -212.00 Mn |
| Dec 31, 2024 | 724.00 Mn |
| Dec 31, 2024 | 724.00 Mn |
| Sep 30, 2024 | 785.00 Mn |
| Sep 30, 2024 | 785.00 Mn |
| Jun 30, 2024 | 792.00 Mn |
| Jun 30, 2024 | 792.00 Mn |
| Mar 31, 2024 | 818.00 Mn |
| Mar 31, 2024 | 818.00 Mn |
| Dec 31, 2023 | 797.00 Mn |
| Dec 31, 2023 | 797.00 Mn |